Theravance Biopharma, Inc. (TBPH)
16.37
+0.03
(+0.18%)
USD |
NASDAQ |
May 22, 16:00
16.38
0.00 (0.00%)
After-Hours: 20:00
Theravance Biopharma Price : 16.37 for May 22, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Viatris, Inc. | 16.65 |
| Relmada Therapeutics, Inc. | 7.04 |
| Indivior Pharmaceuticals, Inc. | 37.53 |
| Corcept Therapeutics, Inc. | 60.22 |
| Assertio Holdings, Inc. | 23.44 |
Price Related Metrics
| PE Ratio | 7.425 |
| PS Ratio | 7.716 |
| Price to Book Value | 2.904 |
| Price to Free Cash Flow | 3.152 |
| Earnings Yield | 13.47% |
| Market Cap | 843.92M |
| Operating PE Ratio | 9625.09 |
| Normalized PE Ratio | 7.262 |